ArticleTherapeutics and clinical risk management2010

Selecting GLP-1 agonists in the management of type 2 diabetes: differential pharmacology and therapeutic benefits of liraglutide and exenatide.

Jonathan Pinkney et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.